Antoine Lafont
15Patents
4h-index
14Co-inventors
57Inventor score
Filing activity: Dec 15, 1997 → Apr 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5957975A | Stent having a programmed pattern of in vivo degradation | Human Necessities | 286 | Expired |
| US7731740B2 | Polymer-based stent assembly | Human Necessities | 54 | Expired |
| US7838021B2 | Platforms, particularly prostheses, having biologically active coverings | Human Necessities | 30 | Expired |
| US7743481B2 | Stent crimping | Emerging Cross-Sectional Technologies | 23 | Active |
| US7951593B2 | Culture medium for gingival fibroblasts | Chemistry; Metallurgy | 4 | Active |
| US8609085B2 | Use of gingival fibroblasts for vascular cell therapy | Human Necessities | 3 | Active |
| US8303948B2 | Method for treating skin wounds | Human Necessities | 3 | Active |
| US10624838B2 | Use of gingival fibroblasts in the treatment of alopecia | Human Necessities | 3 | Active |
| US11229670B2 | Compositions useful for the treatment of immune-related diseases | Human Necessities | 3 | Active |
| US8119122B2 | Use of gingival fibroblasts for vascular cell therapy | Human Necessities | 1 | Active |
| US12351823B2 | Mammalian cell population and medicaments for cell therapies in equines and improved cell cultivation methods | Chemistry; Metallurgy | 0 | Active |
| US12258579B2 | Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods | Chemistry; Metallurgy | 0 | Active |
| US9867971B2 | Device for administering cells and cell-therapy methods using said device | Human Necessities | 0 | Active |
| US12297454B2 | Mammalian cell population and medicaments for cell therapies in canines and improved cell cultivation methods | Chemistry; Metallurgy | 0 | Active |
| US9283094B2 | Polymer-based stent assembly | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.